Articles from Rimona Weil and Suzanne Reeves, Ruth Dobson and Charmaine Yam, Manoj Sivan, Stephen Halpin and Jeremy Gee, Gavin Giovannoni, Yeliz Demir, Fahim Anwar, Judith Allanson, Katie Bond, Emer McGilloway and Harry Mee

An update on the MS Leaders Academy

News from Novartis on the EU approval of Mayzent (siponimod) for adult patients with SPMS with active disease

Those of us in the room have the power we need to fundamentally improve the quality of multiple sclerosis (MS) care in the UK, reduce variation and offer consistent care at the level we want everywhere, in the next 3 years. In July, 85% of 120 healthcare professionals agreed with this statement (‘Raising the Bar’, […]

News from Merck